Literature DB >> 7266379

Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia.

A F Stalenhoef, A F Casparie, P N Demacker, J T Stouten, J A Lutterman, A van 't Laar.   

Abstract

The underlying pathophysiological defect was studied in four siblings with familial hyperchylomicronemia. Deficiency of apolipoprotein C-II and E-3 was identified. In addition, these subjects had markedly decreased LPL activity in postheparin plasma. Addition of normal plasma to the assay as source for apoC-II enhanced LPL activity only to a limited extent. In contrast with previously reported patients with apoC-II deficiency, a far less pronounced effect of intravenous infusion of normal plasma was seen in one of the siblings, probably due to the combined deficiency of apoC-II and LPL. Plasma VLDL-TG turnover rate was not decreased in one of the siblings with apoC-II and LPL deficiency, suggesting different metabolic pathways for chylomicrons and VLDL. Family study confirmed an autosomal recessive mode of inheritance both for apoC-II and for apoE-3 deficiency. The mode of inheritance for LPL deficiency could not be established exactly.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7266379     DOI: 10.1016/0026-0495(81)90072-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  16 in total

1.  Increased hepatic lipase activity and increased direct removal of very-low-density lipoprotein remnants in Watanabe heritable hyperlipidaemic (WHHL) rabbits treated with ethinyl oestradiol.

Authors:  P N Demacker; M J Mol; A F Stalenhoef
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

2.  Pancreatitis induced by oestrogen in a patient with type I hyperlipoproteinaemia.

Authors:  P M Stuyt; P N Demacker; A F Stalenhoef
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

3.  A nonsense mutation in the apolipoprotein C-IIPadova gene in a patient with apolipoprotein C-II deficiency.

Authors:  S S Fojo; P Lohse; C Parrott; G Baggio; C Gabelli; F Thomas; J Hoffman; H B Brewer
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

4.  Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency.

Authors:  S S Fojo; U Beisiegel; U Beil; K Higuchi; M Bojanovski; R E Gregg; H Greten; H B Brewer
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

5.  Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII.

Authors:  C L Jackson; G A Bruns; J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Apo C-II deficiency type Bari.

Authors:  A Capurso; F Resta; F Turturro; A M Colacicco; C Crecchio; G Pepe
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Apolipoprotein CIISt. Michael. Familial apolipoprotein CII deficiency associated with premature vascular disease.

Authors:  P W Connelly; G F Maguire; J A Little
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

8.  A novel type hypertriglyceridemia observed in FLS mice.

Authors:  Masaya Takahashi; Toshiji Saibara; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisawa; Shinji Iwasaki; Katsumi Toda; Yasuhiro Ogawa; Akihiko Wakatsuki; Shuichiro Inagaki; Saburo Onishi
Journal:  Lipids       Date:  2003-07       Impact factor: 1.880

9.  Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.

Authors:  G Baggio; E Manzato; C Gabelli; R Fellin; S Martini; G B Enzi; F Verlato; M R Baiocchi; D L Sprecher; M L Kashyap
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

10.  Familial apolipoprotein CII deficiency: a preliminary analysis of the gene defect in two independent families.

Authors:  S E Humphries; L Williams; O Myklebost; A F Stalenhoef; P N Demacker; G Baggio; G Crepaldi; D J Galton; R Williamson
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.